Local secretion/shedding of tumor-derived CD83 molecules as a novel tumor escape mechanism

Molecular Immunology

Volumn 45, Issue 12, 2008, Pages 3502-3504

  Baleeiro, R B ^a   Barbuto, J A M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CD83; Dendritic cells; Immunosuppression; Tumor escape mechanisms

Indexed keywords

ANTIBODY; CD83 ANTIBODY; CD83 ANTIGEN;

ANTIGEN EXPRESSION; BREAST CANCER; CANCER CELL CULTURE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CULTURE MEDIUM; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; IMMUNOMODULATION; LETTER; LUNG CANCER; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE ACTIVATION; TUMOR CELL; TUMOR ESCAPE;

ANTIGENS, CD; ANTIGENS, NEOPLASM; CELL PROLIFERATION; HUMANS; IMMUNOGLOBULINS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

EID: 44649095119     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.04.005     Document Type: Letter

References (7)

1. Baleeiro R.B., Bergami-Santos P.C., Tomiyoshi M.Y., Gross J.L., Haddad F., Pinto C.A., Soares F.A., Younes R.N., and Barbuto J.A. Expression of a dendritic cell maturation marker CD83 on tumor cells from lung cancer patients and several human tumor cell lines--is there a biological meaning behind it?. Cancer Immunol. Immunother. 57 (2008) 265-270
2. Cao W., Lee S.H., and Lu J. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem. J. 385 (2005) 85-93
3. Hirano N., Butler M.O., Xia Z., Ansen S., von Bergwelt-Baildon M.S., Neuberg D., Freeman G.J., and Nadler L.M. Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood 107 (2006) 1528-1536
4. Hock B.D., Haring L.F., Steinkasserer A., Taylor K.G., Patton W.N., and McKenzie J.L. The soluble form of CD83 is present at elevated levels in a number of hematological malignancies. Leukemia Res. 28 (2004) 237-241
5. Lechmann M., Krooshoop D.J., Dudziak D., Kremmer E., Kuhnt C., Figdor C.G., Schuler G., and Steinkasserer A. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194 (2001) 1813-1821
6. Zhou L., Schwarting R., Smith H.M., and Tedder T.F. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149 (1992) 735-742
7. Zinser E., Lechmann M., Golka A., Lutz M.B., and Steinkasserer A. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200 (2004) 345-351